Extended return policy to 90 days. Read more.
WITH THE POTENTIAL TO PREVENT COVID-19
- Potent neutralization of SARS-CoV-2 virus at low doses.*
- Designed to protect the nasal cavity; the most likely route of COVID-19 exposure for hours.*
- A complement to other COVID-19 preventative measures.
- Intended for everyday use.
*Based on studies performed using in vivo models of SARS-CoV-2 infection. See more details under our Science page.
Directions
- For best result, point the nozzle close to the nostril and spray while inhaling.
Active Ingredients
- High-affinity neutralizing human antibody specific to SARS-CoV-2 spike protein, with proprietary adhesion technology to prolong antibody retention in the respiratory mucosa.
Gladstone Institutes are an independent state-of-the-art biomedical research institution that empowers its world-class scientists to find new pathways to cures. Prof. Warner Greene, who led the validation, is the Founding and Emeritus Director of Gladstone Institute of Virology and Immunology.
Coronavirus Immunotherapy Consortium, a global, academic-industry, non-profit research collaboration. Evaluates antibody-based therapeutics against SARS-CoV-2 with supports from organizations such as the Bill and Melinda Gates Foundation.
